Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial
Open Access
- 21 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (28), 2668-2677
- https://doi.org/10.1093/eurheartj/ehaa293
Abstract
Aims The association of body weight and weight change with mortality and cardiovascular (CV) outcome in patients with diabetes mellitus (DM) is not clearly established. We assessed the relationship between weight, weight change, and outcomes in patients with established CV risk factors and type 2 DM or pre-diabetes. Methods and results A total of 12 521 participants from the ORIGIN trial were grouped in BMI categories of low body weight [body mass index (BMI)= 40kg/m(2), respectively). Outcome variables included total and CV mortality and composite outcomes of CV death, non-fatal stroke, or myocardial infarction plus revascularization or heart failure hospitalization. Follow-up was 6.2years (interquartile range 5.8-6.7years). After multivariable adjustment, lowest risks were seen in patients with overweight and mild obesity for total mortality [overweight: hazard ratio (HR) 0.80 (95% confidence interval (CI) 0.69-0.91); obesity Grade 1: HR 0.82 (0.71-0.95), both P<0.01)] and CV mortality [overweight: HR 0.79 (0.66-0.94); obesity Grade 1: 0.79 (0.65-0.95), all compared to patients with normal BMI, P<0.05]. Obesity of any severity was not associated with higher mortality. Low body weight was related to higher mortality [HR 1.28 (1.02-1.61); CV mortality: HR 1.34 (1.01-1.79), P<0.05]. A continued 2-year weight loss was associated with higher risk of mortality [HR 1.32 (1.18-1.46), P<0.0001] and CV mortality [HR 1.18 (1.02-1.35), compared to patients without weight loss, P<0.05]. In turn, weight gain was not related to any adverse outcome. Conclusion Obesity in patients with DM or pre-diabetes and CV risk profile was not associated with higher mortality or adverse CV outcome. The lowest mortality risk was seen in patients with overweight and moderate obesity (BMI 25-35kg/m(2)). Weight loss was an independent risk factor for higher mortality compared to no weight loss.Funding Information
- Vifor
- Pfizer
- Boehringer Ingelheim
- Sphingotec
- ZS Pharma
- Bayer
- McMaster-Sanofi Population Health Institute Chair in Diabetes Research and Care
This publication has 32 references indexed in Scilit:
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 DiabetesThe New England Journal of Medicine, 2013
- Combining Body Mass Index With Measures of Central Obesity in the Assessment of Mortality in Subjects With Coronary DiseaseJournal of the American College of Cardiology, 2013
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index CategoriesJAMA, 2013
- Basal Insulin and Cardiovascular and Other Outcomes in DysglycemiaThe New England Journal of Medicine, 2012
- Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study populationInternational Journal of Cardiology, 2011
- Body-Mass Index and Mortality among 1.46 Million White AdultsThe New England Journal of Medicine, 2010
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesThe Lancet, 2009
- Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)American Heart Journal, 2008
- Adolescent Overweight and Future Adult Coronary Heart DiseaseThe New England Journal of Medicine, 2007
- Associations between obesity and health conditions may be overestimated if self‐reported body mass index is usedObesity Reviews, 2007